AR227576A1 - Procedimiento para la preparacion de nuevas piridinas antiinflamatorias e inmunorreguladoras - Google Patents

Procedimiento para la preparacion de nuevas piridinas antiinflamatorias e inmunorreguladoras

Info

Publication number
AR227576A1
AR227576A1 AR288464A AR28846482A AR227576A1 AR 227576 A1 AR227576 A1 AR 227576A1 AR 288464 A AR288464 A AR 288464A AR 28846482 A AR28846482 A AR 28846482A AR 227576 A1 AR227576 A1 AR 227576A1
Authority
AR
Argentina
Prior art keywords
piridines
immunor
regulatory
inflammatory
procedure
Prior art date
Application number
AR288464A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR227576A1 publication Critical patent/AR227576A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01DHARVESTING; MOWING
    • A01D34/00Mowers; Mowing apparatus of harvesters
    • A01D34/001Accessories not otherwise provided for
    • A01D34/003Means for cleaning the machine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00Moulds or cores; Details thereof or accessories therefor
    • B29C33/56Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60Releasing, lubricating or separating agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16CSHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00Pivots; Pivotal connections
    • F16C11/04Pivotal connections
    • F16C11/06Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604Construction of the male part
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16CSHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00Pivots; Pivotal connections
    • F16C11/04Pivotal connections
    • F16C11/06Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Composite Materials (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AR288464A 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas antiinflamatorias e inmunorreguladoras AR227576A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AR227576A1 true AR227576A1 (es) 1982-11-15

Family

ID=22188737

Family Applications (3)

Application Number Title Priority Date Filing Date
AR282823A AR226864A1 (es) 1979-10-15 1980-10-09 Procedimiento para la preparacion de 4-(2-hidroxietiltiometil)-piridina antiinflamatoria e inmunorreguladora
AR288464A AR227576A1 (es) 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas antiinflamatorias e inmunorreguladoras
AR288463A AR227089A1 (es) 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas y pirimidinas antiinflamatorias e inmunorreguladoras

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR282823A AR226864A1 (es) 1979-10-15 1980-10-09 Procedimiento para la preparacion de 4-(2-hidroxietiltiometil)-piridina antiinflamatoria e inmunorreguladora

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR288463A AR227089A1 (es) 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas y pirimidinas antiinflamatorias e inmunorreguladoras

Country Status (39)

Country Link
US (1) US4246263A (es)
JP (1) JPS5663962A (es)
KR (2) KR840001614B1 (es)
AR (3) AR226864A1 (es)
AT (2) AT377513B (es)
AU (1) AU517763B2 (es)
BE (1) BE885709A (es)
CA (1) CA1156231A (es)
CH (1) CH646425A5 (es)
CS (2) CS226020B2 (es)
DD (2) DD154816B3 (es)
DE (1) DE3038593A1 (es)
DK (1) DK152427C (es)
EG (1) EG14676A (es)
ES (2) ES495932A0 (es)
FI (1) FI75560C (es)
FR (1) FR2467199A1 (es)
GB (2) GB2092133B (es)
GR (1) GR70311B (es)
HK (2) HK1185A (es)
HU (2) HU183233B (es)
IE (1) IE50665B1 (es)
IL (1) IL61261A (es)
IN (2) IN154554B (es)
IT (1) IT1195269B (es)
KE (2) KE3461A (es)
LU (1) LU82844A1 (es)
MY (2) MY8500323A (es)
NL (1) NL8005652A (es)
NO (1) NO156566C (es)
NZ (1) NZ195246A (es)
PH (1) PH18277A (es)
PL (2) PL125314B1 (es)
PT (1) PT71917B (es)
SE (1) SE437023B (es)
SG (2) SG56384G (es)
SU (2) SU1083907A3 (es)
YU (2) YU41740B (es)
ZA (1) ZA806306B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
ATE67675T1 (de) * 1986-06-17 1991-10-15 Biogen Inc Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.
US6878743B2 (en) * 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
PT1896401E (pt) * 2005-02-25 2013-07-17 Univ Temple Síntese de sulfuretos, sulfonas, sulfóxidos e sulfonamidas não saturados
JP5287033B2 (ja) * 2007-08-23 2013-09-11 住友化学株式会社 含フッ素有機硫黄化合物およびその有害節足動物防除剤
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
CA3115629A1 (en) 2018-10-08 2020-04-16 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
PL227307A1 (es) 1981-11-13
CH646425A5 (fr) 1984-11-30
IT1195269B (it) 1988-10-12
ES505544A0 (es) 1982-08-16
ES8201972A1 (es) 1982-01-16
SE8007193L (sv) 1981-04-16
MY8500323A (en) 1985-12-31
NL8005652A (nl) 1981-04-21
KR830004263A (ko) 1983-07-09
DD202543A5 (de) 1983-09-21
GB2061928B (en) 1983-06-02
AU6324080A (en) 1981-04-30
US4246263A (en) 1981-01-20
DE3038593A1 (de) 1981-04-23
ATA268783A (de) 1985-07-15
SG69184G (en) 1985-03-15
NZ195246A (en) 1983-07-15
KE3466A (en) 1984-11-09
AT379801B (de) 1986-03-10
HK1185A (en) 1985-01-11
YU42059B (en) 1988-04-30
FR2467199A1 (fr) 1981-04-17
JPS6129342B2 (es) 1986-07-05
HU191824B (en) 1987-04-28
NO156566B (no) 1987-07-06
PL231782A1 (es) 1982-03-01
IN163553B (es) 1988-10-08
CS226034B2 (en) 1984-03-19
IN154554B (es) 1984-11-10
IL61261A (en) 1984-08-31
DK152427B (da) 1988-02-29
YU41740B (en) 1987-12-31
CS226020B2 (en) 1984-03-19
KE3461A (en) 1984-10-12
IE50665B1 (en) 1986-06-11
DD154816A5 (de) 1982-04-21
DD154816B3 (de) 1987-05-13
NO156566C (no) 1987-10-14
KR840001615B1 (ko) 1984-10-11
FI75560C (fi) 1988-07-11
GB2061928A (en) 1981-05-20
DE3038593C2 (es) 1988-11-10
ATA508980A (de) 1984-08-15
PL125314B1 (en) 1983-04-30
PL125402B1 (en) 1983-05-31
AU517763B2 (en) 1981-08-27
ES8206478A1 (es) 1982-08-16
EG14676A (en) 1985-03-31
YU262680A (en) 1983-09-30
GB2092133B (en) 1983-03-16
IL61261A0 (en) 1980-12-31
DK403080A (da) 1981-04-16
ES495932A0 (es) 1982-01-16
IT8025324A0 (it) 1980-10-14
FI803239L (fi) 1981-04-16
IE802125L (en) 1981-04-15
KR840001614B1 (ko) 1984-10-11
SG56384G (en) 1985-03-08
SU1144617A3 (ru) 1985-03-07
MY8500325A (en) 1985-12-31
DK152427C (da) 1988-07-25
ZA806306B (en) 1981-10-28
JPS5663962A (en) 1981-05-30
AR226864A1 (es) 1982-08-31
GR70311B (es) 1982-09-08
PH18277A (en) 1985-05-17
YU266882A (en) 1983-09-30
NO803073L (no) 1981-04-21
AT377513B (de) 1985-03-25
CA1156231A (en) 1983-11-01
HK66887A (en) 1987-09-25
BE885709A (fr) 1981-04-14
PT71917B (en) 1983-01-10
PT71917A (en) 1980-12-01
SU1083907A3 (ru) 1984-03-30
FI75560B (fi) 1988-03-31
LU82844A1 (fr) 1981-06-04
SE437023B (sv) 1985-02-04
AR227089A1 (es) 1982-09-15
HU183233B (en) 1984-04-28
FR2467199B1 (es) 1984-12-28
GB2092133A (en) 1982-08-11

Similar Documents

Publication Publication Date Title
ES498225A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491913A0 (es) Procedimiento para la preparacion de betainas
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
ES492566A0 (es) Procedimiento para la preparacion de nuevos derivados de en-cafalina
ES495179A0 (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
AR221355A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil y pirrolidinilmetil-benzamidas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
ES493300A0 (es) Procedimiento para la preparacion de acilureas
AR227576A1 (es) Procedimiento para la preparacion de nuevas piridinas antiinflamatorias e inmunorreguladoras
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
MX6151E (es) Procedimiento para la preparacion de 7-acilindolinas
MX6327E (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden-hidrazinopiridazina
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal
AR223383A1 (es) Procedimiento para la preparacion de 2-isopropilamino-pirimidina
ES497099A0 (es) Procedimiento para la preparacion de sulfonilureas
MX6162E (es) Procedimiento para la preparacion de la 2-isopropilamino-pirimidina
ES495978A0 (es) Procedimiento para la preparacion de nuevos dea-esteroides
ES496862A0 (es) Procedimiento para la preparacion de sulfonil- o sulfinila- cetanilidas fungicidas